Friday, July 11 2025
12:40–1:40pm
Industry Theater
Empowering Treatment Choice with Spravato
Industry Theater 1, Ballroom A4, Level 2
Description
“Empowering Treatment Choice With SPRAVATO®” is an educational program focusing on care options for adult patients with treatment-resistant depression (TRD).
Empowering Treatment Choice With SPRAVATO® (cp-428154v6)
-Review the patient experience and unmet need in treatment-resistant depression (TRD)—major depressive disorder (MDD) with inadequate response to at least 2 oral -antidepressants of adequate dose and duration
-Understanding the mechanism of action for SPRAVATO® (esketamine) CIII nasal spray
-Clinical efficacy data in TRD for SPRAVATO® alone or in combination with an oral antidepressant
-5-year results from a long-term, open-label safety study of SPRAVATO®
-Two ways to connect patients to care with SPRAVATO®: treat or refer
-Important Safety Information